FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128812398> ?p ?o ?g. }

• W2128812398 endingPage "418" @default.
• W2128812398 startingPage "410" @default.
• W2128812398 abstract "The objective of this article is to investigate the combination of telmisartan with vildagliptin therapy versus monotherapy of vildagliptin and telmisartan on diabetic nephropathy in type 2 diabetes mellitus rats.In adult rats streptozotocin (65 mg/kg) and nicotinamide (110 mg/kg) were injected intraperitoneally to produce diabetic nephropathy. Rats of either sex allotted to the following groups: (i) triple therapy: metformin (120 mg/kg, o.d.) + pioglitazone (1.25 mg/kg, o.d.) + glimepiride (0.7 mg/kg, o.d.); (ii) dual therapy: vildagliptin (8.76 mg/kg, o.d.) + telmisartan (6.48 mg/kg, o.d.); (iii) vildagliptin (8.76 mg/kg, o.d.); and (iv) telmisartan (6.48 mg/kg, o.d.); therapy was carried out for 35 days orally. Weekly at days 7, 14, 21, 28 and 35, blood pressure, blood glucose level, body weight, blood serum creatinine level, protein albumin level in urine, and blood urea nitrogen (BUN) were estimated. Renal structural changes were observed.Blood pressure, blood glucose level, blood serum creatinine level, protein albumin level in urine, BUN and renal deterioration increased significantly in diabetic rats compared with normal control rats. The vildagliptin + telmisartan treatment group showed no weight gain and controlled blood pressure, renovascular structural and biochemical parameters in diabetic neuropathy rats.The addition of telmisartan to vildagliptin demonstrated the best control over blood pressure, glycemia and diabetic nephropathy markers, renal structural changes and improvement of renal function as opposed to monotherapy with either drug, possibly because of the dual inhibitory effect on the renin-angiotensin system." @default.
• W2128812398 created "2016-06-24" @default.
• W2128812398 creator A5001719651 @default.
• W2128812398 creator A5019155047 @default.
• W2128812398 creator A5026023639 @default.
• W2128812398 creator A5030922510 @default.
• W2128812398 creator A5032438589 @default.
• W2128812398 creator A5036667376 @default.
• W2128812398 creator A5044112943 @default.
• W2128812398 creator A5047003935 @default.
• W2128812398 creator A5050479763 @default.
• W2128812398 creator A5064620018 @default.
• W2128812398 creator A5084277609 @default.
• W2128812398 date "2013-02-08" @default.
• W2128812398 modified "2023-10-16" @default.
• W2128812398 title "Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats" @default.
• W2128812398 cites W1963596900 @default.
• W2128812398 cites W1984313472 @default.
• W2128812398 cites W2003046651 @default.
• W2128812398 cites W2005156150 @default.
• W2128812398 cites W2033728841 @default.
• W2128812398 cites W2051129372 @default.
• W2128812398 cites W2059561996 @default.
• W2128812398 cites W2121166356 @default.
• W2128812398 cites W2129697991 @default.
• W2128812398 cites W2153933777 @default.
• W2128812398 cites W2157373537 @default.
• W2128812398 cites W2091805433 @default.
• W2128812398 doi "https://doi.org/10.1177/1470320313475908" @default.
• W2128812398 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23396552" @default.
• W2128812398 hasPublicationYear "2013" @default.
• W2128812398 type Work @default.
• W2128812398 sameAs 2128812398 @default.
• W2128812398 citedByCount "13" @default.
• W2128812398 countsByYear W21288123982016 @default.
• W2128812398 countsByYear W21288123982017 @default.
• W2128812398 countsByYear W21288123982018 @default.
• W2128812398 countsByYear W21288123982019 @default.
• W2128812398 countsByYear W21288123982020 @default.
• W2128812398 countsByYear W21288123982021 @default.
• W2128812398 countsByYear W21288123982022 @default.
• W2128812398 countsByYear W21288123982023 @default.
• W2128812398 crossrefType "journal-article" @default.
• W2128812398 hasAuthorship W2128812398A5001719651 @default.
• W2128812398 hasAuthorship W2128812398A5019155047 @default.
• W2128812398 hasAuthorship W2128812398A5026023639 @default.
• W2128812398 hasAuthorship W2128812398A5030922510 @default.
• W2128812398 hasAuthorship W2128812398A5032438589 @default.
• W2128812398 hasAuthorship W2128812398A5036667376 @default.
• W2128812398 hasAuthorship W2128812398A5044112943 @default.
• W2128812398 hasAuthorship W2128812398A5047003935 @default.
• W2128812398 hasAuthorship W2128812398A5050479763 @default.
• W2128812398 hasAuthorship W2128812398A5064620018 @default.
• W2128812398 hasAuthorship W2128812398A5084277609 @default.
• W2128812398 hasBestOaLocation W21288123981 @default.
• W2128812398 hasConcept C126322002 @default.
• W2128812398 hasConcept C134018914 @default.
• W2128812398 hasConcept C159641895 @default.
• W2128812398 hasConcept C2776307423 @default.
• W2128812398 hasConcept C2776453732 @default.
• W2128812398 hasConcept C2777180221 @default.
• W2128812398 hasConcept C2778176769 @default.
• W2128812398 hasConcept C2778384471 @default.
• W2128812398 hasConcept C2779716603 @default.
• W2128812398 hasConcept C2779922275 @default.
• W2128812398 hasConcept C2780306776 @default.
• W2128812398 hasConcept C2781184683 @default.
• W2128812398 hasConcept C2910068830 @default.
• W2128812398 hasConcept C555293320 @default.
• W2128812398 hasConcept C71924100 @default.
• W2128812398 hasConcept C84393581 @default.
• W2128812398 hasConceptScore W2128812398C126322002 @default.
• W2128812398 hasConceptScore W2128812398C134018914 @default.
• W2128812398 hasConceptScore W2128812398C159641895 @default.
• W2128812398 hasConceptScore W2128812398C2776307423 @default.
• W2128812398 hasConceptScore W2128812398C2776453732 @default.
• W2128812398 hasConceptScore W2128812398C2777180221 @default.
• W2128812398 hasConceptScore W2128812398C2778176769 @default.
• W2128812398 hasConceptScore W2128812398C2778384471 @default.
• W2128812398 hasConceptScore W2128812398C2779716603 @default.
• W2128812398 hasConceptScore W2128812398C2779922275 @default.
• W2128812398 hasConceptScore W2128812398C2780306776 @default.
• W2128812398 hasConceptScore W2128812398C2781184683 @default.
• W2128812398 hasConceptScore W2128812398C2910068830 @default.
• W2128812398 hasConceptScore W2128812398C555293320 @default.
• W2128812398 hasConceptScore W2128812398C71924100 @default.
• W2128812398 hasConceptScore W2128812398C84393581 @default.
• W2128812398 hasIssue "4" @default.
• W2128812398 hasLocation W21288123981 @default.
• W2128812398 hasLocation W21288123982 @default.
• W2128812398 hasOpenAccess W2128812398 @default.
• W2128812398 hasPrimaryLocation W21288123981 @default.
• W2128812398 hasRelatedWork W2128812398 @default.
• W2128812398 hasRelatedWork W2267710210 @default.
• W2128812398 hasRelatedWork W2348745344 @default.
• W2128812398 hasRelatedWork W2354590773 @default.
• W2128812398 hasRelatedWork W2355877427 @default.
• W2128812398 hasRelatedWork W2367646526 @default.

• next